These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3146764)

  • 21. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulus properties of d-amphetamine as compared to l-amphetamine.
    Schechter MD
    Eur J Pharmacol; 1978 Feb; 47(4):461-4. PubMed ID: 631192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Discriminative stimulus properties of D-amphetamine: a neuropharmacological review].
    Inagawa K
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):151-65. PubMed ID: 1414035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reinforcing and subjective effects of several anorectics in normal human volunteers.
    Chait LD; Uhlenhuth EH; Johanson CE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):777-83. PubMed ID: 3656112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of propranolol, d-amphetamine and caffeine on ethanol as a discriminative cue.
    Schechter MD
    Eur J Pharmacol; 1974 Nov; 29(1):52-7. PubMed ID: 4435044
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects.
    Perkins KA; Fonte C; Stolinski A; Blakesley-Ball R; Wilson AS
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):275-81. PubMed ID: 16366757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.
    Li M; McMillan DE
    Eur J Pharmacol; 2003 Aug; 476(1-2):79-85. PubMed ID: 12969752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of some phenylethylamines in rhesus monkeys trained to discriminate (+)-amphetamine from saline.
    Woolverton WL; English JA
    Drug Alcohol Depend; 1997 Mar; 44(2-3):79-85. PubMed ID: 9088779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral interaction between cocaine and caffeine: a drug discrimination analysis in rats.
    Harland RD; Gauvin DV; Michaelis RC; Carney JM; Seale TW; Holloway FA
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1017-23. PubMed ID: 2798526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.
    Callahan PM; Appel JB; Cunningham KA
    Psychopharmacology (Berl); 1991; 103(1):50-5. PubMed ID: 2006243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
    Dukat M; Wesolowska A; Young R; Glennon RA
    Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT; Bevins RA; Klebaur JE; Crooks PA; Dwoskin LP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1083-7. PubMed ID: 9408217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
    Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects.
    Young R; Gabryszuk M; Glennon RA
    Pharmacol Biochem Behav; 1998 Oct; 61(2):169-73. PubMed ID: 9738532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine discrimination as a test for anti-parkinsonism drugs.
    Schechter MD
    Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine potentiation of amphetamine: implications for hyperkinesis therapy.
    Schechter MD
    Pharmacol Biochem Behav; 1977 Mar; 6(3):359-61. PubMed ID: 558624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (+)Amphetamine-stimulus generalization to an herbal ephedrine product.
    Glennon RA; Young R
    Pharmacol Biochem Behav; 2000 Apr; 65(4):655-8. PubMed ID: 10764918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.